Search Results
Search for other papers by Sara Lomelino Pinheiro in
Google Scholar
PubMed
Search for other papers by Ana Saramago in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Carmo Martins in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Search for other papers by Tiago Nunes da Silva in
Google Scholar
PubMed
– 19 Song A et al. ( 23 ) 2020 Male 51 2.8 380 c.917T>G p.(Leu306Arg) 20 Pinheiro et al. ( 26 ) 2020 Male 60 3.7 472 c.978C>A p.(Tyr326*) PC, parathyroid carcinoma; PTH, parathyroid hormone
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Kana Yoshioka in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
collection test data (serum calcium, phosphorus, parathyroid hormone (intact PTH), creatinine, alkaline phosphatase (ALP), white blood cell count, and platelet count), and the size of the parathyroid mass were collected from medical charts. The size of the
Parathyroid Unit – LIM-28, Laboratório de Cirurgia de Cabeça e Pescoço, Division of Head and Neck Surgery, Department of Surgery, Hospital das Clinicas (HCFMUSP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Marília D’Elboux Guimarães Brescia in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Karine Candido Rodrigues in
Google Scholar
PubMed
Search for other papers by André Fernandes d’Alessandro in
Google Scholar
PubMed
Search for other papers by Wellington Alves Filho in
Google Scholar
PubMed
Search for other papers by Willemijn Y van der Plas in
Google Scholar
PubMed
Search for other papers by Schelto Kruijff in
Google Scholar
PubMed
Search for other papers by Sergio Samir Arap in
Google Scholar
PubMed
Search for other papers by Sergio Pereira de Almeida Toledo in
Google Scholar
PubMed
Search for other papers by Fábio Luiz de Menezes Montenegro in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Delmar Muniz Lourenço Jr in
Google Scholar
PubMed
/mL). Intact parathyroid hormone levels (PTH) (10–65 pg/mL) were measured using a chemiluminescence assay (DPC, Medlab, San Antonio, TX, USA). All biochemical measures were performed at the time of the preoperative hospitalization, 6 and 12 months after surgery
Search for other papers by Johanna Öberg in
Google Scholar
PubMed
Search for other papers by Rolf Jorde in
Google Scholar
PubMed
Diagnostic Clinic, University Hospital of North Norway, Tromso, Norway
Search for other papers by Yngve Figenschau in
Google Scholar
PubMed
Search for other papers by Per Medbøe Thorsby in
Google Scholar
PubMed
Search for other papers by Sandra Rinne Dahl in
Google Scholar
PubMed
Search for other papers by Anne Winther in
Google Scholar
PubMed
Division of Internal Medicine, University Hospital of North Norway, Tromso, Norway
Search for other papers by Guri Grimnes in
Google Scholar
PubMed
hormonal contraceptives (CHC), which includes an estrogenic component, has been consistently reported ( 3 , 11 ). Several tissues, including the parathyroid gland, can utilize DBP-bound 25(OH)D, possibly modifying the significance of free 25(OH)D levels
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Georgios Kontogeorgos in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Zoi Mamasoula in
Google Scholar
PubMed
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Emily Krantz in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Penelope Trimpou in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Kerstin Landin-Wilhelmsen in
Google Scholar
PubMed
Endocrine Out-Patient Clinic, Carlanderska Hospital, Gothenburg, Sweden
Search for other papers by Christine M Laine in
Google Scholar
PubMed
Introduction Hypoparathyroidism (HypoPT) is a rare endocrine disorder with insufficient levels of parathyroid hormone (PTH), which leads to hypocalcemia and hyperphosphatemia. The phosphate and calcium imbalance increases the risk of ectopic
Search for other papers by Magdaléna Fořtová in
Google Scholar
PubMed
Search for other papers by Lenka Hanousková in
Google Scholar
PubMed
Search for other papers by Martin Valkus in
Google Scholar
PubMed
Search for other papers by Jana Čepová in
Google Scholar
PubMed
Search for other papers by Richard Průša in
Google Scholar
PubMed
Search for other papers by Karel Kotaška in
Google Scholar
PubMed
Introduction About 80–90% of primary hyperparathyroidism (pHPT) cases are caused by parathyroid adenoma. Long-term increased parathyroid hormone (PTH) secretion leads to a generalized disorder of calcium, phosphate and bone metabolism. The
Fondazione Italiana Ricerca sulle Malattie dell’Osso (FIRMO Onlus), Florence, Italy
Search for other papers by Maria Luisa Brandi in
Google Scholar
PubMed
Search for other papers by Stefania Bandinelli in
Google Scholar
PubMed
Search for other papers by Teresa Iantomasi in
Google Scholar
PubMed
Search for other papers by Francesca Giusti in
Google Scholar
PubMed
Search for other papers by Eleonora Talluri in
Google Scholar
PubMed
Search for other papers by Giovanna Sini in
Google Scholar
PubMed
Search for other papers by Fabrizio Nannipieri in
Google Scholar
PubMed
Search for other papers by Santina Battaglia in
Google Scholar
PubMed
Search for other papers by Riccardo Giusti in
Google Scholar
PubMed
Search for other papers by Colin Gerard Egan in
Google Scholar
PubMed
Search for other papers by Luigi Ferrucci in
Google Scholar
PubMed
Introduction Vitamin D is essential for the homeostatic regulation of calcium ( 1 ), and reduced vitamin D intake or inadequate levels can impact upon bone metabolism leading to increased parathyroid hormone (PTH) secretion and increased bone
Search for other papers by Lu Yang in
Google Scholar
PubMed
Search for other papers by Xingguo Jing in
Google Scholar
PubMed
Search for other papers by Hua Pang in
Google Scholar
PubMed
Search for other papers by Lili Guan in
Google Scholar
PubMed
Search for other papers by Mengdan Li in
Google Scholar
PubMed
hormone (PTH) levels are more common in patients with MGD ( 13 , 28 , 29 ). In the case of SPHPT, it is not clear whether MGD represents a neoplastic process or simply that the parathyroid glands are differentially affected and result in asynchronous
Search for other papers by Qian Wang in
Google Scholar
PubMed
Search for other papers by Jiacheng Wang in
Google Scholar
PubMed
Search for other papers by Yunhui Xin in
Google Scholar
PubMed
Search for other papers by Ziyang He in
Google Scholar
PubMed
Search for other papers by Xiang Zhou in
Google Scholar
PubMed
Search for other papers by Xing Liu in
Google Scholar
PubMed
Search for other papers by Teng Zhao in
Google Scholar
PubMed
Search for other papers by Lihan He in
Google Scholar
PubMed
Search for other papers by Hong Shen in
Google Scholar
PubMed
Search for other papers by Mulan Jin in
Google Scholar
PubMed
Search for other papers by Bojun Wei in
Google Scholar
PubMed
repeated surgical resections and have poor prognosis; most die of uncontrollable hypercalcemia due to excessive parathyroid hormone (PTH) secretion ( 5 ), with 5- and 10-year survival rates between 77–91% and 49–77%, respectively ( 1 , 5 , 8 , 9 , 10
College of Medicine, Chang Gung University, Taoyuan, Taiwan
Search for other papers by Heng Yeh in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Hsuan Yeh in
Google Scholar
PubMed
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Chun-Cheng Chiang in
Google Scholar
PubMed
Search for other papers by Ju-Ching Yen in
Google Scholar
PubMed
Department of Nephrology, China Medical University Hospital, Taichung, Taiwan
Search for other papers by I-Kuan Wang in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Shou-Hsuan Liu in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Cheng-Chia Lee in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Cheng-Hao Weng in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Wen-Hung Huang in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Ching-Wei Hsu in
Google Scholar
PubMed
Department of Nephrology, Clinical Poison Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Search for other papers by Tzung-Hai Yen in
Google Scholar
PubMed
Introduction Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD) characterized by the hypersecretion of parathyroid hormone (PTH) and the parathyroid gland hyperplasia stimulated by CKD-related chronic